US FDA•United StatesCRL•Complete Response Letter
Complete Response Letter NDA 505b1 218762 (Apr 17, 2024)
Issued April 17, 2024
Issued
April 17, 2024
Application
NDA 505b1 • 218762
Review center
CDER
Stage
Final Decision
Letter type
Complete Response Letter
Requires resubmission addressing deficiencies.
Document viewer
Read the FDA letter and send context to the co-pilot at any time.